Medtronic has secured FDA approval for its first closed-loop spinal cord stimulator, designed to take in signals from the body and adjust its therapy automatically. The Inceptiv implant for chronic ...
Medtronic said the U.S. Food and Drug Administration has approved a new spinal-cord implant that relieves chronic pain, a bid to expand into a patient population that relies heavily on medications ...
How Medtronic spinal cord stimulation therapy helped one woman reclaim her life. For more than a decade, Lynnette lived in the shadow of debilitating pain. What began as persistent discomfort in her ...
The closed-loop feature of the Inceptiv SCS senses neural responses and is able to automatically adjust stimulation in real time. The Food and Drug Administration (FDA) has approved the Inceptiv ™ ...
David Dinsmoor, the local Medtronic engineer who worked on Inceptiv Medtronic researchers say a recently approved closed-loop spinal cord stimulator marks one of the company’s biggest breakthroughs in ...
Spinal cord stimulation (SCS) therapies for chronic back and/or leg pain is superior to conventional medical management (CMM) for reduced pain intensity and functional disability, new research ...
Medtronic has received FDA clearance for a new implantable pain management device that can be programmed wirelessly via a Samsung tablet. The Intellis system is designed to treat chronic pain by ...
Medtronic has begun enrolling patients in its clinical trial for a back pain treatment device, according to the Memphis Business Journal. The trial is for its peripheral nerve stimulation technique, ...
Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...
Medtronic plc (NYSE: MDT), a global healthcare technology leader, today announced its intent to acquire SPR Therapeutics, Inc. (SPR), a privately held medical technology company and a recognized ...
Exclusive agreement expands Medtronic's comprehensive pain interventions portfolio, increases treatment options for patients living with chronic pain GALWAY, Ireland, March 24, 2026 /PRNewswire/ -- ...